NEW YORK (Reuters Health) – A large retrospective population-based study of patients from the United Kingdom with type 2 diabetes detected a higher incidence of diabetic macular edema…
NEW YORK (Reuters Health) – An episode of herpes zoster is associated with an increased risk of developing anterior uveitis in the following year, according to the results…
NEW YORK (Reuters Health) – A study conducted at Moorfields Eye Hospital in London, UK, finds that the benefits seen at 1 year with bevacizumab treatment of macular…
NEW YORK (Reuters Health) – A Canadian study confirms an increased risk of uveitis and scleritis in first-time users of oral bisphosphonates. “Patients taking bisphosphonates must be familiar…
NEW YORK (Reuters Health) – Results of two trials indicate that verteporfin photodynamic therapy plus ranibizumab injections is no better than ranibizumab alone for treating subfoveal choroidal neovascularization…
NEW YORK (Reuters Health) – In patients undergoing cataract surgery, topical anesthesia doesn’t provide the same degree of pain relief as regional anesthesia although it’s associated with fewer…
NEW YORK (Reuters Health) – Postcataract surgery endophthalmitis rates in the United States declined slightly between 2003 and 2004, but there is still room for improvement, according to…
NEW YORK (Reuters Health) – For preterm neonates at risk of retinopathy, high-dose vitamin A supplementation started soon after birth produces a significant increase in retinal function, a…
NEW YORK (Reuters Health) – Patients with type 2 diabetes who don’t have retinopathy at baseline have a relatively low risk of developing eye complications during 5 to…
NEW YORK (Reuters Health) – A single dose of oral azithromycin reduces the recurrence of trichiasis for up to three years more so than a six-week regimen of…
